The results demonstrated that CYP2U1 was mainly detected in the cytoplasm of breast cancer tissue, while in non-cancer breast tissue, CYP2U1 was mainly located in the nucleus of cells derived from myoepithelial differentiation. Here, CYP2U1 is linked to breast carcinoma.